Lyophilized coformulation (10 mg total) of retatrutide (LY3437943), a triagonist of the GIP, GLP-1 and glucagon receptors, with cagrilintide (AM833 / NN9838), a long-acting amylin analog that is an agonist of the amylin receptors (AMY1R/AMY2R/AMY3R) and of the receptor. For research (RUO).
